退伍军人事务部系统内动脉移植物选择与结局:47,525例患者20年回顾
基于退伍军人事务部企业数据仓库,纳入2003至2023年47,525例体外循环下冠状动脉旁路移植术退伍军人,倾向性评分匹配比较单动脉与多动脉移植的生存。匹配后30天死亡率无差异,但多动脉移植5年、10年、15年死亡率均显著低于单动脉移植。
要点
- 多动脉移植在退伍军人中可行且安全。
- 匹配后30天死亡率多动脉与单动脉无差异。
- 多动脉移植5年起死亡率显著低于单动脉移植。
核心结论
- 在退伍军人事务部人群中,多动脉移植可行且安全,与单动脉移植相比从术后5年起死亡率改善。
研究设计与样本
- 基于退伍军人事务部企业数据仓库的回顾性队列分析,纳入2003年10月1日至2023年9月30日期间在退伍军人事务部医院系统内接受体外循环冠状动脉旁路移植术的退伍军人,共47,525例,采用倾向性评分匹配比较单动脉移植与多动脉移植的生存。
主要发现
- 倾向性评分匹配得到3,286对匹配患者,匹配后30天死亡率多动脉移植1.31%对单动脉移植1.34%(P=1.00),无差异。
- 匹配后5年死亡率多动脉移植14.1%对单动脉移植16.3%(P=.018),10年27.1%对32.2%(P<.001),15年36.7%对41.7%(P<.001),均支持多动脉移植。
- 匹配后30天心肌梗死率单动脉移植3.68%对多动脉移植2.98%(P=.130),30天经皮冠状动脉介入率两组均为0.70%(P=1.00),脑血管事件多动脉移植1.67%对单动脉移植2.07%(P=.275)。
临床怎么用
- 在退伍军人冠状动脉旁路移植术患者中,可考虑多动脉移植以改善长期生存,但需注意30天内心肌梗死率单动脉移植略高但无统计学差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: There is increasing interest in expanding the use of multiarterial grafting (MAG) in coronary artery bypass grafting due to improved long-term patency rates and outcomes. These outcomes have not been reviewed extensively in veterans. METHODS: Using the Veterans Affairs Corporate Data Warehouse, veterans who underwent coronary artery bypass grafting surgery using cardiopulmonary bypass within the Veterans Administration hospital system from October 1, 2003, through September 30, 2023, were analyzed. Propensity score matching compared survival in patients undergoing single artery grafting (SAG) versus MAG. RESULTS: A total of 47,525 veterans were identified. One thousand eighty-four patients underwent internal thoracic artery and radial artery grafting, 2549 underwent bilateral internal thoracic artery grafting, and 43,892 underwent single internal thoracic artery grafting. Propensity score matching yielded 3286 pairs. In these matched patients, there was no difference in 30-day mortality: 1.31% MAG versus 1.34% SAG (P = 1.00). By 5 years, this diverged with a statistically significant lower mortality noted with MAG (14.1%) compared with SAG (16.3%) (P = .018). This trend continued at 10 years (27.1% vs 32.2%; P < .001) and 15 years (36.7% vs 41.7%; P < .001), all favoring MAG. Rates of 30-day myocardial infarction remained slightly higher with SAG (3.68%) versus MAG (2.98%) (P = .130). There was no difference in 30-day percutaneous coronary intervention (0.70% MAG vs 0.70% SAG; P = 1.00) or cerebrovascular events (1.67% MAG vs 2.07% SAG; P = .275). CONCLUSIONS: MAG is feasible and safe within the Veterans Administration population. Compared with SAG, MAG in veterans is associated with improved mortality beginning at 5 years postoperatively.
引用
- Volk L, Cornwell L, Pajaro O, et al. Arterial graft choice and outcomes within the Veterans Administration: A 20-year review of 47,525 patients. J Thorac Cardiovasc Surg. 2025. PMID: 41110500. doi:10.1016/j.jtcvs.2025.09.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。